We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Meeting With FDA This Month to Discuss cGMP Problems
Andrx Meeting With FDA This Month to Discuss cGMP Problems
November 11, 2005
Andrx plans to meet with the FDA around Thanksgiving to discuss manufacturing violations that have stalled approval of its drug applications.